TY  - GEN
AU  - Zangari,Maurizio
AU  - Aujay,Monette
AU  - Zhan,Fenghuang
AU  - Hetherington,Kristina L
AU  - Berno,Tamara
AU  - Vij,Ravi
AU  - Jagannath,Sundar
AU  - Siegel,David
AU  - Keith Stewart,A
AU  - Wang,Luhua
AU  - Orlowski,Robert Z
AU  - Belch,Andrew
AU  - Jakubowiak,Andrzej
AU  - Somlo,George
AU  - Trudel,Suzanne
AU  - Bahlis,Nizar
AU  - Lonial,Sagar
AU  - Singhal,Seema
AU  - Kukreti,Vishal
AU  - Tricot,Guido
TI  - Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients
SN  - 1600-0609
PY  - 2011///0809
KW  - Alkaline Phosphatase
KW  - blood
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Boronic Acids
KW  - Bortezomib
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Oligopeptides
KW  - Osteogenesis
KW  - drug effects
KW  - Protease Inhibitors
KW  - Proteasome Inhibitors
KW  - Pyrazines
KW  - Retrospective Studies
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1111/j.1600-0609.2011.01602.x
ER  -